SENZA SenzaGen AB

STO · SE · Healthcare · Diagnostics & Research · senzagen.com

4.520SEK-0.22%Mkt Cap: 14.05M $P/E: —Today

SenzaGen AB provides non-animal tests for assessing allergenicity. The company offers GARD skin OECD 442E, GARD skin dose-response, GARD skin medical device; and GARD air, a respiratory sensitization assessment. It also …

Industry Peers

Diagnostics & Research

Screen all

TMO

Thermo Fisher Scientific Inc Common Stock

$242.11BUSDP/E 35.5

DHR

Danaher Corporation Common Stock

$150.48BUSDP/E 38.2

NTRA

Natera, Inc. - Common Stock

Agilent Technologies, Inc. Common Stock

$47.30BUSDP/E 33.1

IQV

IQVIA Holdings, Inc. Common Stock

$42.50BUSDP/E 32.2

WAT

Waters Corporation Common Stock

$41.75BUSDP/E 107.4

ILMN

Illumina, Inc. - Common Stock

$41.23BUSDP/E 50.8

IDXX

IDEXX Laboratories, Inc. - Common Stock

$40.89BUSDP/E 36.4

MTD

Mettler-Toledo International, Inc. Common Stock

$29.78BUSDP/E 34.0

DGX

Quest Diagnostics Incorporated Common Stock

$25.75BUSDP/E 25.0

Labcorp Holdings Inc. Common Stock

$25.02BUSDP/E 25.5

Guardant Health, Inc. - Common Stock

$23.86BUSD

RVTY

Revvity, Inc. Common Stock

$16.91BUSDP/E 72.5

MEDP

Medpace Holdings, Inc. - Common Stock

$16.73BUSDP/E 35.2

ERF

Eurofins Scientific SE

$14.05BUSDP/E 26.2

CRL

Charles River Laboratories International, Inc. Common Stock

$13.85BUSD

ICLR

ICON plc - Ordinary Shares

Qiagen N.V. Common Shares

$9.24BUSDP/E 22.7

Key Statistics

Company

Market Cap14.05M USD

Enterprise Value12.30M USD

Revenue (TTM)5.84M USD

Gross Profit3.59M USD

Net Income (TTM)-1.11M USD

Revenue/Share2.07 SEK

Last Price4.520 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees34

CountrySE

SectorHealthcare

IndustryDiagnostics & Research

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-45.30

PEG—

EV/EBITDA-71.31

EV/Revenue2.11

P/S2.41

P/B1.64

EPS (TTM)-0.35

EPS (Forward)-0.10

52W Range

4.5001% of range6.840

52W High6.840 SEK

52W Low4.500 SEK

Profitability

Gross Margin64.80%

Oper. Margin-13.84%

EBITDA Margin-2.95%

Profit Margin-19.99%

ROE-14.91%

ROA-9.98%

Growth

Revenue Growth13.20%

Earnings Growth—

Cash Flow & Leverage

Operating CF-652.63K USD

CapEx (TTM)524.84K USD

FCF Margin-13.02%

FCF Yield-5.41%

Net Debt-1.79M USD

Net Debt/EBITDA10.37

Balance Sheet

Debt/Equity0.24

Current Ratio2.90

Quick Ratio2.64

Book Value/Sh2.77 SEK

Cash/Share1.09 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.32.51M

Float24.42M

Insiders23.61%

Institutions12.16%

Technical

SMA 505.051 (-10.5%)

SMA 2005.387 (-16.1%)

Beta0.58

S&P 52W Chg14.58%

Avg Vol (30d)15.89K

Avg Vol (10d)14.12K

Technical Indicators

RSI (14)29.8

MACD-0.1398

MACD Signal-0.1146

MACD Hist.-0.0251

BB Upper5.149 SEK

BB Middle4.829 SEK

BB Lower4.508 SEK

BB Width13.29%

ATR (14)0.1767 SEK

Vol Ratio (20d)0.36x